Pharmafile Logo

Succeeding with Star Wars Medicine

May 5, 2020 |  

OPEN Health have published a new white paper demonstrating their commitment to leading the conversation on how effective healthcare communications, and tools that enable them, can lead to faster and sustained patient access to gene and other advanced therapies. We brought together experience and capabilities from across our practices to develop broad thinking on ‘Succeeding with Star Wars Medicine – translating the science and value of gene therapy to key stakeholders’. The thinking is based on three key foundations:

  • Leading a patient first approach
  • Communicating the science
  • Demonstrating Value
Pink divider

Please find below a link to a short video of our director of rare disease, Gavin Jones, describing why we have invested in this white paper and what you can expect from our recommendations.

Video link –  https://vimeo.com/414772814

Pink divider

To arrange a virtual presentation to discuss the findings and to receive a copy of the white paper please contact: gavinjones@openhealthgroup.com

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

The right measurement frameworks matter for demonstrating treatment efficacy in clinical trials for Alzheimer’s Disease

The right measurement frameworks matter for demonstrating treatment efficacy in clinical trials for Alzheimer’s Disease

OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe

OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe

Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice

Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice

Embracing the Patient Voice Within Publications

This whitepaper will explore multidisciplinary perspectives on how we can better engage patient communities in publications to optimize the value of their contributions, while navigating any uncertainties and reluctance from...

Navigating the nocebo effect through patient engagement is the key to setting patients up for success

If you're interested in delving deeper into this topic and understanding how patient engagement can effectively navigate the nocebo effect, we invite you to explore our latest whitepaper.

OPEN Health announces a new team of experts will lead its HEOR & Market Access Scientific Office

OPEN Health, a global provider of consultancy, HEOR and market access, and scientific communications services, announced a new team of experts will lead its HEOR & Market Access Scientific Office.

OPEN Health Appoints Richard Jones as President for Evidence & Access

OPEN Health is pleased to announce the appointment of Richard Jones as President for Evidence & Access.

Drive, Discover, Dive_OPEN Health

Learn how to unlock the power of simplicity in complex omnichannel healthcare communications.

Novel Oncology Therapies Require Innovative Methods in Oncology Modeling

Innovative methods in oncology modeling are needed to demonstrate the value of many new cancer treatments, including immuno-oncologic therapies.

The CM Group rebrands to OPEN Health

Following its acquisition by OPEN Health in 2022, The CM Group, a US healthcare agency offering a suite of solutions to the biotech and pharma industry, has undergone extensive rebranding...